CDP vs CRL · P/E 24, rev $398.0M vs rev $2.00B
COPT Defense Properties (CDP) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
COPT Defense Properties (CDP) is a reit - office company listed on NYSE.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported CDP revenue for 2026-06-30 was $398.0M. Net income was $88.7M. Revenue was up 98.4% from 2026-03-31 to 2026-06-30. CDP currently screens at market cap $3.84B and trailing P/E 24.3.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
CDP currently screens at market cap $3.84B and trailing P/E 24.3. CRL currently screens at market cap $7.78B.
Not investment advice. Open the CDP and CRL stock pages for the full models.
Not investment advice.